Company: SMNR
Filing Date: 2025-07-02
Form Type: S-4/A
Source: 0001193125-25-154936
Chunk: 656

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-02
Form: S-4/A
Chunk 656
---
 claim for which the federal district courts of the United States of America are the sole and exclusive forum.

#### Denali Private Placement Units
The Denali Private Placement Units (including the Denali Private Placement Shares, the Denali Private Placement Warrants and Denali Class A Ordinary Shares issuable upon exercise of such warrants) will not be transferable or salable until 30 days after the completion of our initial business combination (except, among other limited exceptions to our officers and directors and other persons or entities affiliated with our sponsor). Holders of our Denali Private Placement Units are entitled to certain registration rights. If we do not consummate an initial business combination by December 11, 2025 (or as may be extended by the Shareholder Extension Period, as applicable), the proceeds from the sale of the Denali Private Placement Units held in the trust account will be used to fund the redemption of our public shares (subject to the requirements of applicable law) and the Denali Private Placement Units (and the underlying securities) will expire worthless. Further, if we seek shareholder approval, we will complete our initial business combination only if we receive an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. In such case, our initial holders, sponsor and each director and executive officer have agreed to vote their founder shares, placement shares and any public shares purchased during or after the IPO in favor of our initial business combination. Otherwise, the Denali Private Placement Units are identical to the Public Units sold in the IPO.

#### Denali Private Placement Warrants
Except as described below, the Denali Private Placement Warrants included in the Denali Private Placement Units have terms and provisions that are identical to those of the warrants being sold as part of the units in the IPO. The Denali Private Placement Warrants (including the Denali Class A Ordinary Shares issuable upon exercise of the Denali Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination (except pursuant to limited exceptions to our officers and directors and other persons or entities affiliated with the initial purchasers of the Denali Private Placement Warrants). Any amendment to the terms of the Denali Private Placement Warrants or any provision of the Warrant Agreement with respect to the Denali Private Placement Warrants requires a vote of holders of a majority of the number of the then outstanding warrants. As of October 23, 2024